Screening and management for portal hypertension in hepatocellular carcinoma: A nationwide survey in China [0.03%]
中国肝细胞癌患者门脉高压筛查和管理的全国调查
Xueyan Li,Huiyu Chen,Qingqing Zhang et al.
Xueyan Li et al.
Introduction and objectives: Hepatocellular carcinoma (HCC) and portal hypertension (PHT) are two common complications of cirrhosis that often co-exist and significantly affect patient prognosis, yet global management var...
Seoung Hoon Kim
Seoung Hoon Kim
Clostridium butyricum reduces the incidence of overt hepatic encephalopathy in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt (TIPS) [0.03%]
结肠细菌Clostridium butyricum可降低经颈静脉肝内门体分流术患者肝性脑病的发病率
Xiaotong Xu,Tong Zhu,Changyou Jing et al.
Xiaotong Xu et al.
Introduction and objectives: Hepatic encephalopathy (HE) is a major complication after transjugular intrahepatic portal shunt (TIPS), affecting patients' quality of life. This study evaluated the efficacy of Clostridium b...
Comment on "Comparisons of global incidence and risk factor profiles of hepatocellular carcinoma and intrahepatic cholangiocarcinoma" [0.03%]
关于“肝细胞癌和肝内胆管癌的全球发病率及危险因素特征比较”的点评
Zhiwei Wang,Lujie Xiang,Lingli Ye et al.
Zhiwei Wang et al.
Jeffrey V Lazarus,Mário G Pessoa,Debbie L Shawcross et al.
Jeffrey V Lazarus et al.
The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver disease [0.03%]
非洲胃肠病协会（AGMA）临床实践指南：与代谢紊乱相关脂肪肝的诊断和管理
Yasser Fouad,Reda Elwakil,Faisal M Sanai et al.
Yasser Fouad et al.
Over the past few decades, the profile of liver diseases in Africa and the Middle East has undergone significant changes. The incidence of metabolic dysfunction-associated fatty liver disease (MAFLD) has risen to alarming levels. Despite th...
Practice Guideline
Annals of hepatology. 2026 Jan 9:102180. DOI:10.1016/j.aohep.2026.102180 2026
De novo malignancies after liver transplantation: a 30-year multicenter Brazilian cohort [0.03%]
巴西多中心肝移植后新发恶性肿瘤：30年队列研究
Larissa Machado E Silva Gomide,Julio Cezar Uili Coelho,Alexandre Coutinho Teixeira de Freitas et al.
Larissa Machado E Silva Gomide et al.
Introduction and objectives: De novo malignancy (DNM) is a major late hazard after liver transplantation (LT), usually due to cumulative immunosuppression, viral oncogenesis, and host/environmental factors. Robust Brazili...
Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinoma [0.03%]
帕博利珠单抗对晚期肝细胞癌患者病毒性肝炎负荷和转氨酶的影响
Stephen Lam Chan,Richard S Finn,Julien Edeline et al.
Stephen Lam Chan et al.
Outcomes and risk of relapse after living donor and deceased donor liver transplantation for alcohol-associated liver disease [0.03%]
酒精相关性肝病患者活体供肝和脑死亡 donors 供肝肝移植的预后及复发风险比较研究
Chloe Huen-Wai Choy,Hills King-Hei Suen,Tiffany Cho-Lam Wong et al.
Chloe Huen-Wai Choy et al.
Introduction and objectives: The six-month abstinence rule for alcohol-associated liver disease (ALD) patients may exclude candidates from life-saving transplantation without reliably predicting relapse. We compared outco...
A three-gene resistome signature as a prognostic tool in hepatocellular carcinoma [0.03%]
三种基因耐药标志物可作为肝细胞癌预后的工具
Anabel Sanchez-Martin,Rocio I R Macias,Luis Muñoz-Bellvís et al.
Anabel Sanchez-Martin et al.
Introduction and objectives: Outcomes for patients with hepatocellular carcinoma (HCC) are generally poor, partly due to significant multidrug resistance. HCC heterogeneity decreases the accuracy of traditional prediction...